title: CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes.
abstract: Since an efficient control of virus infections may depend on the appropriate lymphokine profile, we studied cytokine responses and CD30 induction, a recently proposed surrogate marker of type 2 cells, in 10 healthy anti-hepatitis C virus (HCV)-seropositive blood donors without viremia (group A) and in 15 patients with hepatitis C (group B). Intracytoplasmic IFN-gamma, IL-2, IL-4, and IL-10 were determined by triple-color flow cytometry in the CD3+ and CD3+/CD30+ lymphocyte subsets after stimulation of PBMC with rHCV core protein and five core-derived peptides corresponding to the four immunodominant Th epitopes C.T1 to C.T4. In group A, more type 1 cytokines were induced by the rHCV core protein and all immunodominant core peptides (p < 0.05), whereas IL-10-producing T cells were found more frequently in group B. Induction of CD30+ T cells was found almost exclusively in group B (p < 0.01). The difference in cytokine responses was due to the CD3+/CD30- T cell subset and not the CD3+/CD30+ subset, which predominantly produced both IL-10 and IFN-gamma, but only small amounts of IL-2 and IL-4. We conclude that immunodominant HCV core peptides induce preferentially type 1 cytokines in healthy anti-HCV-positive blood donors and CD30 expression in patients with chronic hepatitis C. However, in both groups, CD30+ T lymphocytes produce an intermediate Th0-like cytokine profile. Thus, chronicity in HCV infection may reflect a lack of type 1 cytokine production.
authors.affiliation: Department of General Internal Medicine, University of Bonn, Germany. UMM21E@ibm.rhrz.uni-bonn.de
authors.forename: R P
authors.initials: RP
authors.lastname: Woitas
authors.forename: M
authors.initials: M
authors.lastname: Lechmann
authors.forename: G
authors.initials: G
authors.lastname: Jung
authors.forename: R
authors.initials: R
authors.lastname: Kaiser
authors.forename: T
authors.initials: T
authors.lastname: Sauerbruch
authors.forename: U
authors.initials: U
authors.lastname: Spengler
mesh_terms: D000328:Adult; D000368:Aged; D017951:Antigen Presentation; D002908:Chronic Disease; D016207:Cytokines / Q000276:immunology*; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000276:immunology*; D018936:Hepatitis C Antigens / Q000276:immunology; D006801:Humans; D017730:Ki-1 Antigen / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D014758:Viral Core Proteins / Q000276:immunology*
chemical_list: D016207:Cytokines; D018936:Hepatitis C Antigens; D017730:Ki-1 Antigen; D014758:Viral Core Proteins; C069130:nucleocapsid protein, Hepatitis C virus